The New Eugenics
By Michael Dorsey,
World Watch
| 06. 30. 2002
On a not too distant horizon, advances in human biotechnology
may enable us to engineer the specific genetic makeup of our
children. Only a few months ago, the headlinemaking Italian
doctor Severino Antinori claimed to have implanted cloned embryos
in several women. We are already at the stage where we can selectively
terminate our offspring if certain genetic criteria are not
met. Soon it may be possible to discern, and ultimately select
for or against, individual traits in our children.
It is at this juncture that the promise of biotechnology runs
head-on into the history and the horrors of eugenics— the
quest for biological “improvement” through reproductive
control.
At the start of the 20th century, British scientist Francis
Galton coined the term eugenics, from the Greek eugenes, for
“well-born.” He later distinguished two major kinds
of eugenics, positive and negative. “Positive eugenics”
was preferential breeding of socalled “superior individuals”
in order to improve the genetic stock of the human race. “Negative
eugenics” meant discouraging or legally prohibiting reproduction
by individuals thought to have “inferior” genes and
was to be “achieved...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...